Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

RCEL holding history

AVITA Medical, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCEL overviewAll 13F holders of RCELFull Q2 2026 holdings

Shares (Q2 2026)
84,033
Value
$347.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RCEL by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202684,033$347.1K<0.1%+21,579+34.6%AddedHolders
Q1 202662,454$231.1K<0.1%−27,855−30.8%ReducedHolders
Q4 202590,309$311.6K<0.1%+14,909+19.8%AddedHolders
Q3 202575,400$385.3K<0.1%−334,399−81.6%ReducedHolders
Q2 2025409,799$2.17M<0.1%+65,071+18.9%AddedHolders
Q1 2025344,728$2.81M<0.1%+216,098+168.0%AddedHolders
Q4 2024128,630$1.65M<0.1%+110,824+622.4%AddedHolders
Q3 202417,806$190.9K<0.1%+686+4.0%AddedHolders
Q2 202417,120$135.6K<0.1%−34,396−66.8%ReducedHolders
Q1 202451,516$825.8K<0.1%+31,509+157.5%AddedHolders
Q4 202320,007$274.5K<0.1%+7,258+56.9%AddedHolders
Q3 202312,749$186.3K<0.1%−4,729−27.1%ReducedHolders
Q2 202317,478$297.3K<0.1%+11,470+190.9%AddedHolders
Q1 20236,008$83.9K<0.1%+5,282+727.5%AddedHolders
Q4 2022726$4.79K<0.1%+476+190.4%AddedHolders
Q3 2022250$1.00K<0.1%−1,023−80.4%ReducedHolders
Q2 20221,273$6.00K<0.1%−136−9.7%ReducedHolders
Q1 20221,409$13.0K<0.1%−35,820−96.2%ReducedHolders
Q4 202137,229$445.0K<0.1%+21,042+130.0%AddedHolders
Q3 202116,187$287.0K<0.1%+14,987+1,248.9%AddedHolders
Q2 20211,200$25.0K<0.1%−12,922−91.5%ReducedHolders
Q1 202114,122$280.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.